Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alloxan diabetes, methylthiouracil, cortisone, and adrenaline affect how white mice hair follicles use glucose and cystine and their cell division.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

The hydrogel speeds up diabetic wound healing by adapting to glucose levels and releasing insulin.

The new hyaluronic acid gel is as safe and effective for lip enhancement as the existing product.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

The zinc-coordinated nanogel therapy speeds up wound healing after pancreas surgery by balancing metabolism and fighting bacteria.

The hydrogel effectively stops bleeding and heals diabetic wounds quickly.

New method improves copper peptide delivery for hair growth three times better than current options.

Improved CRBN ligands make protein degraders more effective and drug-like.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Metformin lowers gremlin-1 and improves insulin resistance in women with PCOS.

Enhanced stem cells can reduce fat buildup in eye tissue for Graves' disease.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

Certain short peptides can increase root hair growth in tobacco plants.

The hydrogel speeds up diabetic wound healing and reduces scarring.

Tridax procumbens significantly lowers blood sugar in diabetic rats.

The injectable hydrogel effectively speeds up chronic wound healing.

A new drug strategy improves hair loss treatment with better results and safety.

Lepidium sativum seed extracts helped reduce inflammation and improve insulin response in obese rats on a high-fat diet.

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

The glucose and NHA combination shows promise for hair regrowth.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

Elagolix did not effectively treat polycystic ovary syndrome.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

New diabetes tech and therapies improve care for endocrine disorders.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Peptide drugs now target hard-to-reach proteins more effectively and specifically.